Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity - Wikidata - wikimedia - TriplyDB

Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity

Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity

http://www.wikidata.org/entity/Q35702905

about

Obstructive sleep apnea as a risk factor for type 2 diabetes mellitus Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea New frontiers in obstructive sleep apnoea Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms Restless legs syndrome and cardiovascular disease: a research roadmap.Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.Association between nocturnal hypoxia and liver injury in the setting of nonalcoholic fatty liver disease.Obstructive Sleep Apnea Syndrome is Associated with Metabolic Syndrome among Adolescents and Youth in Beijing: data from Beijing Child and Adolescent Metabolic Syndrome Study.Resveratrol attenuates intermittent hypoxia-induced macrophage migration to visceral white adipose tissue and insulin resistance in male mice.Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease.Recognition and treatment of sleep-disordered breathing: an important component of chronic disease management.The polymorphic and contradictory aspects of intermittent hypoxia Altered nutrient response of mTORC1 as a result of changes in REDD1 expression: effect of obesity vs. REDD1 deficiency.Carotid body denervation prevents fasting hyperglycemia during chronic intermittent hypoxia Metabolic consequences of high-fat diet are attenuated by suppression of HIF-1α.Intermittent hypoxia-induced glucose intolerance is abolished by α-adrenergic blockade or adrenal medullectomy Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease.Toll-like receptor-4 mediated inflammation is involved in the cardiometabolic alterations induced by intermittent hypoxia.Uncoupling protein-2 mRNA expression in mice subjected to intermittent hypoxia.Vascular and hepatic impact of short-term intermittent hypoxia in a mouse model of metabolic syndrome Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.Effect of diabetes mellitus on sleep quality Effect of Intermittent Hypoxia and Rimonabant on Glucose Metabolism in Rats: Involvement of Expression of GLUT4 in Skeletal Muscle.Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target?Aberrant REDD1-mTORC1 responses to insulin in skeletal muscle from Type 2 diabetics Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea.Sleep Apnea in Type 2 Diabetes.Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.Sleep Apnea Research in Animals. Past, Present, and Future.Objectively measured sleep characteristics and prevalence of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis Sleep study.Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure Association of obstructive sleep apnea and glucose metabolism in subjects with or without obesity.The Role of Acute Intermittent Hypoxia in Neutrophil-Generated Superoxide, Sympathovagal Balance, and Vascular Function in Healthy Subjects.Obesity and sleep-disordered breathing--when two 'bad guys' meet.Hypoxia and fatty liver.Biological plausibility linking sleep apnoea and metabolic dysfunction.Effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia in the frequently sampled intravenous glucose tolerance test.Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction.OSA and cardiometabolic risk: What's the bottom line?

P2860

Q26778430-C6434F6B-730C-4DC0-9BC5-0793712396E7 Q26783727-EB783EBF-D8A6-44C1-A5D5-5595B1257273 Q26823972-61359938-F6D8-4BFF-BB22-C285411AD49E Q26849304-5DFA3699-CDB7-4654-904B-865CCAB52B5F Q28390983-2A3AE735-622D-4EEA-ACD4-3BD495B01F8E Q30239115-45A2D165-70DE-42B3-BD8F-1D0B34E69DDD Q30251565-ED42A157-456E-456B-864A-4AC4969D5445 Q30418433-A454979D-06B8-4295-A809-1FB1D6CC2255 Q30990423-7D29F123-7B4B-49A9-9B5F-1BE425C81666 Q33569634-255B91A9-95A7-4B17-8271-AC4197267071 Q33583409-CAFE7B0D-C054-4CBD-83B9-3A37DC4FD18E Q33730115-A29F26A2-906F-444C-B165-03BF2F728554 Q33913792-3418D10A-A89D-425A-A0A6-ED471550B92D Q34006278-0BAB9A1B-E836-4042-A476-2E967337305A Q34295327-29162521-F406-4188-BA4F-5124B1091458 Q34437691-D6F6245A-B7C1-40F9-A297-D7806E84FF98 Q34627676-BBC5256A-B327-40C1-A0CB-F0A4D2C6C264 Q35157250-6BD58477-7D23-4211-BFC2-7CD6B39ED6EA Q35250450-10DEFCDB-20BC-452F-9684-8FF4D1B001A0 Q35597819-AF9E6F34-38BC-4CE1-95A0-2175197F5177 Q35636669-87E6DC5B-DC5F-459D-91C2-3DF396EAC627 Q35704508-4B79E0ED-504B-441E-8FF7-2AA86C9D286A Q35774101-7ADCB086-D941-4542-8DDD-596473DB0A06 Q36239149-BC6C65C4-C31A-4C14-A1A6-F814D4DB2BFD Q36323458-4B4A8097-F180-43DA-8EF6-AC5C6B85224B Q36339315-F2E465BB-72DD-4676-886D-888FC988C9E2 Q36556215-016D7D22-C9F6-4D1D-B1C5-57F3571B52B4 Q36585200-D4F711C1-6832-47E7-93D9-B179638C619A Q36752050-088616E5-1F39-400E-97B8-C8FF85A1274A Q36765905-390A129B-4A1F-4EC1-A206-740437B610AF Q36874144-0AB01847-E002-4D4B-A10D-A4DFF81BE1F8 Q37171152-F0375691-93C2-4F70-ACA2-FFA8300A643D Q37331136-159544ED-8FC9-4A71-AD41-12B996193797 Q37597956-B32F748F-7BE6-49C5-91F2-8ED942B6CA43 Q38186508-22D8CFA2-90B2-41B4-8D1C-F7AF3C691DCB Q38266865-B8BC55D1-10A8-406C-80EE-FEC1E983A2F1 Q38759460-5707516C-C07D-40F3-9F19-FF0A329C2CEA Q39011220-D5993C5F-A73E-4421-A472-0482CE0A8D30 Q39024401-25214689-D00B-42E2-BDD1-0C4C3F883D54 Q39120083-E1D16312-4CE0-4E9B-A37F-24E3A4EF16D6

P2860

Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity

http://www.wikidata.org/entity/Q35702905

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity

@ast

Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity

@en

type

label

Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity

@ast

Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity

@en

prefLabel

Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity

@ast

Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity

@en

P1433

Q35702905-5339C545-412B-4C4F-87C7-794DD4CBE8BE

P1476

Q35702905-B1C95676-EB8F-4856-903B-EBEE84DCE274

P2093

Q35702905-100C22B1-DC20-416E-B313-0E3DEA30D8E2

Q35702905-202297C9-8104-46CA-8594-E6967D42ECEA

Q35702905-5B3AB0D0-9B00-4674-A44F-E8D1C6553AE7

Q35702905-74759EC1-DA89-40FA-8947-3018DD41F82E

Q35702905-79D4163B-41A7-4A7B-B453-D017F130D20C

Q35702905-ABD29FCF-84E8-46C2-8313-944B09BC4DE6

P2860

Q35702905-04073E42-F4F4-459A-9F78-070E31DBF5CA

Q35702905-051A10CC-76FE-49F8-A2E5-68B799F6F6D0

Q35702905-0617BED6-FC32-470B-B792-0975061DA436

Q35702905-0F35C6CA-E05B-4BC6-9F85-5160B45E1CE3

Q35702905-1290BD5E-628A-49BB-AA24-39DCBBF0C38B

Q35702905-1E811011-EE61-4C15-AF54-E7A6A20C8337

Q35702905-244403BE-EF08-4C09-91A2-A91576A62350

Q35702905-25171303-DD89-46C5-B8C2-D8C83E78871D

Q35702905-26FCAE42-919A-4D2B-A171-4A24FAB53F05

Q35702905-3C11BBE0-9C04-4E78-9166-0A7A0D14CF0A

P304

Q35702905-797F4F31-ED56-4AFF-ABAB-41E89B116452

P31

Q35702905-B4A763E5-8E7E-45B1-8906-A6DF67278BDE

P356

Q35702905-26750640-94C3-46FF-8DE1-FC9A15A2E3BB

P433

Q35702905-3D0BDBBC-528F-45F5-BA8D-CA4A94FBE3B5

P478

Q35702905-7378E83C-8712-40FD-82EE-F3BA488CEE69

P577

Q35702905-C6C62A3B-3038-47EE-B90B-B8463C64C46B

P5875

Q35702905-501573CB-D786-46A2-8506-5A3F45BA3EA3

P698

Q35702905-A92A37AA-731B-49FF-8075-9D34E5D881F1

P921

Q35702905-15E29B50-8AAA-4CF5-AE09-7C575B07F97C

Q35702905-D3BE0F69-6C3F-4A03-BFDC-D2F0844E5C60

P932

Q35702905-695C0EDC-E3B4-4D2C-ADBF-15A61AFEB298

P356

P1433

P1476

Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity

@en

P2093

Christian Reinke

http://www.w3.org/2001/XMLSchema#string

Jianguo Li

http://www.w3.org/2001/XMLSchema#string

Jonathan C Jun

http://www.w3.org/2001/XMLSchema#string

Luciano F Drager

http://www.w3.org/2001/XMLSchema#string

Shannon Bevans-Fonti

http://www.w3.org/2001/XMLSchema#string

Vsevolod Y Polotsky

http://www.w3.org/2001/XMLSchema#string

P2860

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

Free fatty acids and insulin resistance

Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia

Prevalence and trends in obesity among US adults, 1999-2008

Mechanisms linking obesity to insulin resistance and type 2 diabetes

Molecular mediators of hepatic steatosis and liver injury

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

Lipid homeostasis, lipotoxicity and the metabolic syndrome.

Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure.

P304

2167-2174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/OBY.2011.240

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51530885

http://www.w3.org/2001/XMLSchema#string

P698

21799478

http://www.w3.org/2001/XMLSchema#string

P921

P932

4461029

http://www.w3.org/2001/XMLSchema#string